Page last updated: 2024-11-05

tyramine and Invasiveness, Neoplasm

tyramine has been researched along with Invasiveness, Neoplasm in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Thus, CpdA likely inhibits bladder cancer growth predominantly via inducing GR transrepression and at least partially mediated through the AR pathway, suggesting its effects more beneficial than GCs/pure GR ligands or AR antagonists."1.42Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression. ( Ide, H; Inoue, S; Ishiguro, H; Jalalizadeh, M; Kashiwagi, E; Kawahara, T; Miyamoto, H; Reis, LO; Zheng, Y, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, Y1
Ishiguro, H1
Ide, H1
Inoue, S1
Kashiwagi, E1
Kawahara, T1
Jalalizadeh, M1
Reis, LO1
Miyamoto, H1
Kaufmann, O1
Baume, H1
Dietel, M1

Other Studies

2 other studies available for tyramine and Invasiveness, Neoplasm

ArticleYear
Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Molecular endocrinology (Baltimore, Md.), 2015, Volume: 29, Issue:10

    Topics: Acetates; Androgen Antagonists; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation

2015
Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.
    The Journal of pathology, 1998, Volume: 186, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biotin; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme T

1998